Pharmacists soon to provide shingles management

Herpes Zoster (HZ), or shingles, is a common viral infection, with one in three people developing the condition in their lifetime.

High interruption rates threaten patient safety

New research has found that pharmacists are interrupted at alarming rates when dispensing medicines. Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...

Prescription rule changes to support telehealth

Australia’s Chief Health Officer has approved an amendment to PBS prescription requirements for telehealth consultations as an emergency measure during the COVID-19 response.

Neuropathic pain medicines can increase the risk of falls

These oft-used medicines have become the analgesia of choice for many prescribers. But care should be taken before prescribing gabapentinoids to certain patients. Gabapentinoid medicines...

Date of birth now required on all NSW scripts

From 1 November 2022, the date of birth of every patient must be included on all prescriptions for Schedule 4 and Schedule 8 medicines.

How to save a life with naloxone

By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.